Global Venous Thromboembolism Treatment Options Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 92

Published Date: 04 Sep 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Venous Thromboembolism Treatment Options market size was valued at USD 366.8 million in 2022 and is forecast to a readjusted size of USD 462 million by 2029 with a CAGR of 3.3% during review period.

The most common treatment for deep vein thrombosis is the use of anticoagulants, also known as blood thinners. These medicines, which can be taken by injection or pill, can reduce your blood's ability to clot. They don't break down existing clots, but they prevent them from getting bigger and reduce the risk of more clots forming. Injectable drugs can be given either subcutaneously or intravenously.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Venous Thromboembolism Treatment Options industry chain, the market status of Hospitals (Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves), Catheterisation Laboratories (Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Venous Thromboembolism Treatment Options.

Regionally, the report analyzes the Venous Thromboembolism Treatment Options markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Venous Thromboembolism Treatment Options market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Venous Thromboembolism Treatment Options market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Venous Thromboembolism Treatment Options industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Venous Thromboembolism Treatment Options market.

Regional Analysis: The report involves examining the Venous Thromboembolism Treatment Options market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Venous Thromboembolism Treatment Options market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Venous Thromboembolism Treatment Options:
Company Analysis: Report covers individual Venous Thromboembolism Treatment Options manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Venous Thromboembolism Treatment Options This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Catheterisation Laboratories).

Technology Analysis: Report covers specific technologies relevant to Venous Thromboembolism Treatment Options. It assesses the current state, advancements, and potential future developments in Venous Thromboembolism Treatment Options areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Venous Thromboembolism Treatment Options market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Venous Thromboembolism Treatment Options market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Others

Market segment by Application
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers

Major players covered
AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Venous Thromboembolism Treatment Options product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Venous Thromboembolism Treatment Options, with price, sales, revenue and global market share of Venous Thromboembolism Treatment Options from 2018 to 2023.
Chapter 3, the Venous Thromboembolism Treatment Options competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Venous Thromboembolism Treatment Options breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Venous Thromboembolism Treatment Options market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Venous Thromboembolism Treatment Options.
Chapter 14 and 15, to describe Venous Thromboembolism Treatment Options sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Venous Thromboembolism Treatment Options
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Venous Thromboembolism Treatment Options Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Upper Pneumatic Compression Sleeves
        1.3.3 Lower Pneumatic Compression Sleeves
        1.3.4 Permanent Inferior Vena Cava Filters
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Venous Thromboembolism Treatment Options Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Catheterisation Laboratories
        1.4.4 Ambulatory Surgical Centers
    1.5 Global Venous Thromboembolism Treatment Options Market Size & Forecast
        1.5.1 Global Venous Thromboembolism Treatment Options Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Venous Thromboembolism Treatment Options Sales Quantity (2018-2029)
        1.5.3 Global Venous Thromboembolism Treatment Options Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 AngioDynamics
        2.1.1 AngioDynamics Details
        2.1.2 AngioDynamics Major Business
        2.1.3 AngioDynamics Venous Thromboembolism Treatment Options Product and Services
        2.1.4 AngioDynamics Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AngioDynamics Recent Developments/Updates
    2.2 Cardinal Health Inc.
        2.2.1 Cardinal Health Inc. Details
        2.2.2 Cardinal Health Inc. Major Business
        2.2.3 Cardinal Health Inc. Venous Thromboembolism Treatment Options Product and Services
        2.2.4 Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Cardinal Health Inc. Recent Developments/Updates
    2.3 BTG International Ltd.
        2.3.1 BTG International Ltd. Details
        2.3.2 BTG International Ltd. Major Business
        2.3.3 BTG International Ltd. Venous Thromboembolism Treatment Options Product and Services
        2.3.4 BTG International Ltd. Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 BTG International Ltd. Recent Developments/Updates
    2.4 Stryker Corporation
        2.4.1 Stryker Corporation Details
        2.4.2 Stryker Corporation Major Business
        2.4.3 Stryker Corporation Venous Thromboembolism Treatment Options Product and Services
        2.4.4 Stryker Corporation Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Stryker Corporation Recent Developments/Updates
    2.5 DJO Global Inc.
        2.5.1 DJO Global Inc. Details
        2.5.2 DJO Global Inc. Major Business
        2.5.3 DJO Global Inc. Venous Thromboembolism Treatment Options Product and Services
        2.5.4 DJO Global Inc. Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 DJO Global Inc. Recent Developments/Updates
    2.6 EKOS Corp
        2.6.1 EKOS Corp Details
        2.6.2 EKOS Corp Major Business
        2.6.3 EKOS Corp Venous Thromboembolism Treatment Options Product and Services
        2.6.4 EKOS Corp Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 EKOS Corp Recent Developments/Updates
    2.7 Teleflex Inc., Boston Scientific Corp.
        2.7.1 Teleflex Inc., Boston Scientific Corp. Details
        2.7.2 Teleflex Inc., Boston Scientific Corp. Major Business
        2.7.3 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product and Services
        2.7.4 Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
    2.8 Janssen Pharmaceuticals, Inc
        2.8.1 Janssen Pharmaceuticals, Inc Details
        2.8.2 Janssen Pharmaceuticals, Inc Major Business
        2.8.3 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product and Services
        2.8.4 Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Janssen Pharmaceuticals, Inc Recent Developments/Updates

3 Competitive Environment: Venous Thromboembolism Treatment Options by Manufacturer
    3.1 Global Venous Thromboembolism Treatment Options Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Venous Thromboembolism Treatment Options Revenue by Manufacturer (2018-2023)
    3.3 Global Venous Thromboembolism Treatment Options Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Venous Thromboembolism Treatment Options by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Venous Thromboembolism Treatment Options Manufacturer Market Share in 2022
        3.4.2 Top 6 Venous Thromboembolism Treatment Options Manufacturer Market Share in 2022
    3.5 Venous Thromboembolism Treatment Options Market: Overall Company Footprint Analysis
        3.5.1 Venous Thromboembolism Treatment Options Market: Region Footprint
        3.5.2 Venous Thromboembolism Treatment Options Market: Company Product Type Footprint
        3.5.3 Venous Thromboembolism Treatment Options Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Venous Thromboembolism Treatment Options Market Size by Region
        4.1.1 Global Venous Thromboembolism Treatment Options Sales Quantity by Region (2018-2029)
        4.1.2 Global Venous Thromboembolism Treatment Options Consumption Value by Region (2018-2029)
        4.1.3 Global Venous Thromboembolism Treatment Options Average Price by Region (2018-2029)
    4.2 North America Venous Thromboembolism Treatment Options Consumption Value (2018-2029)
    4.3 Europe Venous Thromboembolism Treatment Options Consumption Value (2018-2029)
    4.4 Asia-Pacific Venous Thromboembolism Treatment Options Consumption Value (2018-2029)
    4.5 South America Venous Thromboembolism Treatment Options Consumption Value (2018-2029)
    4.6 Middle East and Africa Venous Thromboembolism Treatment Options Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2029)
    5.2 Global Venous Thromboembolism Treatment Options Consumption Value by Type (2018-2029)
    5.3 Global Venous Thromboembolism Treatment Options Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2029)
    6.2 Global Venous Thromboembolism Treatment Options Consumption Value by Application (2018-2029)
    6.3 Global Venous Thromboembolism Treatment Options Average Price by Application (2018-2029)

7 North America
    7.1 North America Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2029)
    7.2 North America Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2029)
    7.3 North America Venous Thromboembolism Treatment Options Market Size by Country
        7.3.1 North America Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2029)
        7.3.2 North America Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2029)
    8.2 Europe Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2029)
    8.3 Europe Venous Thromboembolism Treatment Options Market Size by Country
        8.3.1 Europe Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2029)
        8.3.2 Europe Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Venous Thromboembolism Treatment Options Market Size by Region
        9.3.1 Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Venous Thromboembolism Treatment Options Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2029)
    10.2 South America Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2029)
    10.3 South America Venous Thromboembolism Treatment Options Market Size by Country
        10.3.1 South America Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2029)
        10.3.2 South America Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Venous Thromboembolism Treatment Options Market Size by Country
        11.3.1 Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Venous Thromboembolism Treatment Options Market Drivers
    12.2 Venous Thromboembolism Treatment Options Market Restraints
    12.3 Venous Thromboembolism Treatment Options Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Venous Thromboembolism Treatment Options and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Venous Thromboembolism Treatment Options
    13.3 Venous Thromboembolism Treatment Options Production Process
    13.4 Venous Thromboembolism Treatment Options Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Venous Thromboembolism Treatment Options Typical Distributors
    14.3 Venous Thromboembolism Treatment Options Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Venous Thromboembolism Treatment Options Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Venous Thromboembolism Treatment Options Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. AngioDynamics Basic Information, Manufacturing Base and Competitors
    Table 4. AngioDynamics Major Business
    Table 5. AngioDynamics Venous Thromboembolism Treatment Options Product and Services
    Table 6. AngioDynamics Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. AngioDynamics Recent Developments/Updates
    Table 8. Cardinal Health Inc. Basic Information, Manufacturing Base and Competitors
    Table 9. Cardinal Health Inc. Major Business
    Table 10. Cardinal Health Inc. Venous Thromboembolism Treatment Options Product and Services
    Table 11. Cardinal Health Inc. Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Cardinal Health Inc. Recent Developments/Updates
    Table 13. BTG International Ltd. Basic Information, Manufacturing Base and Competitors
    Table 14. BTG International Ltd. Major Business
    Table 15. BTG International Ltd. Venous Thromboembolism Treatment Options Product and Services
    Table 16. BTG International Ltd. Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. BTG International Ltd. Recent Developments/Updates
    Table 18. Stryker Corporation Basic Information, Manufacturing Base and Competitors
    Table 19. Stryker Corporation Major Business
    Table 20. Stryker Corporation Venous Thromboembolism Treatment Options Product and Services
    Table 21. Stryker Corporation Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Stryker Corporation Recent Developments/Updates
    Table 23. DJO Global Inc. Basic Information, Manufacturing Base and Competitors
    Table 24. DJO Global Inc. Major Business
    Table 25. DJO Global Inc. Venous Thromboembolism Treatment Options Product and Services
    Table 26. DJO Global Inc. Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. DJO Global Inc. Recent Developments/Updates
    Table 28. EKOS Corp Basic Information, Manufacturing Base and Competitors
    Table 29. EKOS Corp Major Business
    Table 30. EKOS Corp Venous Thromboembolism Treatment Options Product and Services
    Table 31. EKOS Corp Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. EKOS Corp Recent Developments/Updates
    Table 33. Teleflex Inc., Boston Scientific Corp. Basic Information, Manufacturing Base and Competitors
    Table 34. Teleflex Inc., Boston Scientific Corp. Major Business
    Table 35. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Product and Services
    Table 36. Teleflex Inc., Boston Scientific Corp. Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Teleflex Inc., Boston Scientific Corp. Recent Developments/Updates
    Table 38. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
    Table 39. Janssen Pharmaceuticals, Inc Major Business
    Table 40. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Product and Services
    Table 41. Janssen Pharmaceuticals, Inc Venous Thromboembolism Treatment Options Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Janssen Pharmaceuticals, Inc Recent Developments/Updates
    Table 43. Global Venous Thromboembolism Treatment Options Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 44. Global Venous Thromboembolism Treatment Options Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 45. Global Venous Thromboembolism Treatment Options Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 46. Market Position of Manufacturers in Venous Thromboembolism Treatment Options, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 47. Head Office and Venous Thromboembolism Treatment Options Production Site of Key Manufacturer
    Table 48. Venous Thromboembolism Treatment Options Market: Company Product Type Footprint
    Table 49. Venous Thromboembolism Treatment Options Market: Company Product Application Footprint
    Table 50. Venous Thromboembolism Treatment Options New Market Entrants and Barriers to Market Entry
    Table 51. Venous Thromboembolism Treatment Options Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Venous Thromboembolism Treatment Options Sales Quantity by Region (2018-2023) & (K Units)
    Table 53. Global Venous Thromboembolism Treatment Options Sales Quantity by Region (2024-2029) & (K Units)
    Table 54. Global Venous Thromboembolism Treatment Options Consumption Value by Region (2018-2023) & (USD Million)
    Table 55. Global Venous Thromboembolism Treatment Options Consumption Value by Region (2024-2029) & (USD Million)
    Table 56. Global Venous Thromboembolism Treatment Options Average Price by Region (2018-2023) & (US$/Unit)
    Table 57. Global Venous Thromboembolism Treatment Options Average Price by Region (2024-2029) & (US$/Unit)
    Table 58. Global Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2023) & (K Units)
    Table 59. Global Venous Thromboembolism Treatment Options Sales Quantity by Type (2024-2029) & (K Units)
    Table 60. Global Venous Thromboembolism Treatment Options Consumption Value by Type (2018-2023) & (USD Million)
    Table 61. Global Venous Thromboembolism Treatment Options Consumption Value by Type (2024-2029) & (USD Million)
    Table 62. Global Venous Thromboembolism Treatment Options Average Price by Type (2018-2023) & (US$/Unit)
    Table 63. Global Venous Thromboembolism Treatment Options Average Price by Type (2024-2029) & (US$/Unit)
    Table 64. Global Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2023) & (K Units)
    Table 65. Global Venous Thromboembolism Treatment Options Sales Quantity by Application (2024-2029) & (K Units)
    Table 66. Global Venous Thromboembolism Treatment Options Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. Global Venous Thromboembolism Treatment Options Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. Global Venous Thromboembolism Treatment Options Average Price by Application (2018-2023) & (US$/Unit)
    Table 69. Global Venous Thromboembolism Treatment Options Average Price by Application (2024-2029) & (US$/Unit)
    Table 70. North America Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2023) & (K Units)
    Table 71. North America Venous Thromboembolism Treatment Options Sales Quantity by Type (2024-2029) & (K Units)
    Table 72. North America Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2023) & (K Units)
    Table 73. North America Venous Thromboembolism Treatment Options Sales Quantity by Application (2024-2029) & (K Units)
    Table 74. North America Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2023) & (K Units)
    Table 75. North America Venous Thromboembolism Treatment Options Sales Quantity by Country (2024-2029) & (K Units)
    Table 76. North America Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2023) & (USD Million)
    Table 77. North America Venous Thromboembolism Treatment Options Consumption Value by Country (2024-2029) & (USD Million)
    Table 78. Europe Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Europe Venous Thromboembolism Treatment Options Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Europe Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2023) & (K Units)
    Table 81. Europe Venous Thromboembolism Treatment Options Sales Quantity by Application (2024-2029) & (K Units)
    Table 82. Europe Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2023) & (K Units)
    Table 83. Europe Venous Thromboembolism Treatment Options Sales Quantity by Country (2024-2029) & (K Units)
    Table 84. Europe Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2023) & (USD Million)
    Table 85. Europe Venous Thromboembolism Treatment Options Consumption Value by Country (2024-2029) & (USD Million)
    Table 86. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2023) & (K Units)
    Table 87. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Type (2024-2029) & (K Units)
    Table 88. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2023) & (K Units)
    Table 89. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Application (2024-2029) & (K Units)
    Table 90. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Region (2018-2023) & (K Units)
    Table 91. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity by Region (2024-2029) & (K Units)
    Table 92. Asia-Pacific Venous Thromboembolism Treatment Options Consumption Value by Region (2018-2023) & (USD Million)
    Table 93. Asia-Pacific Venous Thromboembolism Treatment Options Consumption Value by Region (2024-2029) & (USD Million)
    Table 94. South America Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2023) & (K Units)
    Table 95. South America Venous Thromboembolism Treatment Options Sales Quantity by Type (2024-2029) & (K Units)
    Table 96. South America Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2023) & (K Units)
    Table 97. South America Venous Thromboembolism Treatment Options Sales Quantity by Application (2024-2029) & (K Units)
    Table 98. South America Venous Thromboembolism Treatment Options Sales Quantity by Country (2018-2023) & (K Units)
    Table 99. South America Venous Thromboembolism Treatment Options Sales Quantity by Country (2024-2029) & (K Units)
    Table 100. South America Venous Thromboembolism Treatment Options Consumption Value by Country (2018-2023) & (USD Million)
    Table 101. South America Venous Thromboembolism Treatment Options Consumption Value by Country (2024-2029) & (USD Million)
    Table 102. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Type (2018-2023) & (K Units)
    Table 103. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Type (2024-2029) & (K Units)
    Table 104. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Application (2018-2023) & (K Units)
    Table 105. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Application (2024-2029) & (K Units)
    Table 106. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Region (2018-2023) & (K Units)
    Table 107. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity by Region (2024-2029) & (K Units)
    Table 108. Middle East & Africa Venous Thromboembolism Treatment Options Consumption Value by Region (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Venous Thromboembolism Treatment Options Consumption Value by Region (2024-2029) & (USD Million)
    Table 110. Venous Thromboembolism Treatment Options Raw Material
    Table 111. Key Manufacturers of Venous Thromboembolism Treatment Options Raw Materials
    Table 112. Venous Thromboembolism Treatment Options Typical Distributors
    Table 113. Venous Thromboembolism Treatment Options Typical Customers
List of Figures
    Figure 1. Venous Thromboembolism Treatment Options Picture
    Figure 2. Global Venous Thromboembolism Treatment Options Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Venous Thromboembolism Treatment Options Consumption Value Market Share by Type in 2022
    Figure 4. Upper Pneumatic Compression Sleeves Examples
    Figure 5. Lower Pneumatic Compression Sleeves Examples
    Figure 6. Permanent Inferior Vena Cava Filters Examples
    Figure 7. Others Examples
    Figure 8. Global Venous Thromboembolism Treatment Options Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Venous Thromboembolism Treatment Options Consumption Value Market Share by Application in 2022
    Figure 10. Hospitals Examples
    Figure 11. Catheterisation Laboratories Examples
    Figure 12. Ambulatory Surgical Centers Examples
    Figure 13. Global Venous Thromboembolism Treatment Options Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Venous Thromboembolism Treatment Options Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Venous Thromboembolism Treatment Options Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Venous Thromboembolism Treatment Options Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Venous Thromboembolism Treatment Options Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Venous Thromboembolism Treatment Options Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Venous Thromboembolism Treatment Options by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Venous Thromboembolism Treatment Options Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Venous Thromboembolism Treatment Options Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Venous Thromboembolism Treatment Options Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Venous Thromboembolism Treatment Options Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Venous Thromboembolism Treatment Options Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Venous Thromboembolism Treatment Options Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Venous Thromboembolism Treatment Options Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Venous Thromboembolism Treatment Options Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Venous Thromboembolism Treatment Options Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Venous Thromboembolism Treatment Options Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Venous Thromboembolism Treatment Options Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Venous Thromboembolism Treatment Options Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Venous Thromboembolism Treatment Options Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Venous Thromboembolism Treatment Options Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Venous Thromboembolism Treatment Options Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Venous Thromboembolism Treatment Options Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Venous Thromboembolism Treatment Options Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Venous Thromboembolism Treatment Options Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Venous Thromboembolism Treatment Options Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Venous Thromboembolism Treatment Options Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Venous Thromboembolism Treatment Options Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Venous Thromboembolism Treatment Options Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Venous Thromboembolism Treatment Options Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Venous Thromboembolism Treatment Options Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Venous Thromboembolism Treatment Options Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Venous Thromboembolism Treatment Options Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Venous Thromboembolism Treatment Options Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Venous Thromboembolism Treatment Options Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Venous Thromboembolism Treatment Options Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Venous Thromboembolism Treatment Options Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Venous Thromboembolism Treatment Options Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Venous Thromboembolism Treatment Options Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Venous Thromboembolism Treatment Options Market Drivers
    Figure 76. Venous Thromboembolism Treatment Options Market Restraints
    Figure 77. Venous Thromboembolism Treatment Options Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Venous Thromboembolism Treatment Options in 2022
    Figure 80. Manufacturing Process Analysis of Venous Thromboembolism Treatment Options
    Figure 81. Venous Thromboembolism Treatment Options Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AngioDynamics
Cardinal Health Inc.
BTG International Ltd.
Stryker Corporation
DJO Global Inc.
EKOS Corp
Teleflex Inc., Boston Scientific Corp.
Janssen Pharmaceuticals, Inc

Related Reports

Global Venous Thromboembolism Treatment Options Supply, Demand and Key Producers, 2023-2029

Global Venous Thromboembolism Treatment Options Supply, Demand and Key Producers, 2023-2029

date 04 Sep 2023

date Medical Care

The global Venous Thromboembolism Treatment Options market size is expected to reach $ 462 million by 2029, rising at a market growth of 3.3% CAGR during the forecast period (2023-2029).

Global Venous Thromboembolism Treatment Options Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Venous Thromboembolism Treatment Options Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Venous Thromboembolism Treatment Options market size was valued at USD 366.8 million in 2023 and is forecast to a readjusted size of USD 462 million by 2030 with a CAGR of 3.3% during review period.

Product Tags

Venous Thromboembolism Treatment Options

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>